Related Experiment Videos
Donor mononuclear cell infusions as therapy for B-cell lymphoproliferative disorder following allogeneic bone marrow
D L Porter1, G J Orloff, J H Antin
1Harvard Medical School, Boston, MA.
Transplantation Science
|September 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Bendamustine is safe and effective for lymphodepletion before tisagenlecleucel in patients with refractory or relapsed large B-cell lymphomas.
Annals of oncology : official journal of the European Society for Medical Oncology·2022
Low EGF in myeloablative allotransplantation: association with severe acute GvHD in BMT CTN 0402.
Bone marrow transplantation·2017
The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Reduced-intensity conditioned allogeneic SCT in adults with AML.
Bone marrow transplantation·2015
Cytokines and transplantation: a clinical perspective.
Transplantation science·1994
Induction therapy with OKT3 in pediatric liver-transplant recipients.
Transplantation science·1994
Induction with OKT3 and prostaglandin E1 in liver transplantation.
Transplantation science·1994
Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders.
Transplantation science·1994
Secondary malignancies after marrow transplantation for leukemia or aplastic anemia.
Transplantation science·1994
Inspiratory muscle strength and post-liver transplantation outcomes: safety of measurement in the ICU ‒ an observational study.
Clinics (Sao Paulo, Brazil)·2026